Publications
All
Strategic Views
all strategic viewsIndia 2024: Navigating Market Turbulence to Amplify Long-Term Investment Gains
DownloadBullish for India Assets: USD Negative Trend, Fed Pause, Lower Inflation, and Neutral Oil Outlook
DownloadStrategic case for investing in India in the current business cycle
DownloadUS Equity market has entered a bear market territory — how low can the markets fall in 2022???
DownloadMarket Comments
all market commentsResearch
More
Zogenix, Inc.
A pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders.
Dicerna Pharmaceuticals, Inc.
A ribonucleic acid (RNA) interference-based biopharmaceutical company, which silences genes and restores health.
27.02.2024
2024's Untapped Fixed Income Opportunity: Exploring India's Eurobonds with 5-7% USD Yields20.10.2023
Redefining Cash Returns: India's Government Bonds – The 7.2% Yield Game-Changer